Literature DB >> 8825909

Outer membrane protein CD of Branhamella catarrhalis: sequence conservation in strains recovered from the human respiratory tract.

C B Hsiao1, S Sethi, T F Murphy.   

Abstract

Branhamella catarrhalis causes lower respiratory tract infections in patients with chronic obstructive pulmonary disease. The outer membrane protein CD (OMP-CD) of B. catarrhalis is a major, heat-modifiable OMP. The goals of this study are to characterize the degree of conservation of OMP-CD among strains and to investigate if OMP-CD maintains its homogeneity under the effect of host immune selective pressure. Isolates of B. catarrhalis were collected prospectively from patients with bronchiectasis and chronic bronchitis. We studied the OMP-CD gene by analysis of PCR restriction fragment length polymorphisms (PCR-RFLP) and further determined DNA sequence of the CD gene of eight selected isolates. Five patterns of PCR-RFLP of the OMP-CD gene were observed among all isolates when the gene was digested with Sau3AI. The sequence analysis revealed a high degree of homogeneity in OMP-CD among strains of B. catarrhalis. Three regions of OMP-CD with minimal sequence heterogeneity were identified. The sequences of the OMP-CD gene of isolates collected from patients colonized with the same strain for up to 6 months was identical. These observations establish that the OMP-CD of B. catarrhalis recovered from clinical isolates is highly conserved among strains.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8825909     DOI: 10.1016/s0882-4010(95)90272-4

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  23 in total

1.  Characterization of a novel porin protein from Moraxella catarrhalis and identification of an immunodominant surface loop.

Authors:  Donna M Easton; Adam Smith; Sara Gomez Gallego; A Ruth Foxwell; Allan W Cripps; Jennelle M Kyd
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

2.  Analysis of antigenic structure and human immune response to outer membrane protein CD of Moraxella catarrhalis.

Authors:  T F Murphy; C Kirkham; E DeNardin; S Sethi
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 3.  Potential impact of a Moraxella catarrhalis vaccine in COPD.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Vaccine       Date:  2017-02-06       Impact factor: 3.641

4.  Expression of the Moraxella catarrhalis UspA1 protein undergoes phase variation and is regulated at the transcriptional level.

Authors:  E R Lafontaine; N J Wagner; E J Hansen
Journal:  J Bacteriol       Date:  2001-03       Impact factor: 3.490

5.  Moraxella catarrhalis strain O35E expresses two filamentous hemagglutinin-like proteins that mediate adherence to human epithelial cells.

Authors:  Rachel Balder; Jonathan Hassel; Serena Lipski; Eric R Lafontaine
Journal:  Infect Immun       Date:  2007-03-19       Impact factor: 3.441

6.  Characterization of the Moraxella catarrhalis uspA1 and uspA2 genes and their encoded products.

Authors:  L D Cope; E R Lafontaine; C A Slaughter; C A Hasemann; C Aebi; F W Henderson; G H McCracken; E J Hansen
Journal:  J Bacteriol       Date:  1999-07       Impact factor: 3.490

Review 7.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

8.  Moraxella catarrhalis outer membrane protein CD elicits antibodies that inhibit CD binding to human mucin and enhance pulmonary clearance of M. catarrhalis in a mouse model.

Authors:  Dai-Fang Liu; John C McMichael; Steven M Baker
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

9.  The Hag protein of Moraxella catarrhalis strain O35E is associated with adherence to human lung and middle ear cells.

Authors:  Melissa M Holm; Serena L Vanlerberg; Darren D Sledjeski; Eric R Lafontaine
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

Review 10.  A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.